Full Press Release Details
Lexicon Strengthens Management Team With Two New Executives.
LXRX
Lexicon Strengthens Management Team With Two New Executives
Key Takeaway: Lexicon Strengthens Management Team With Two New Executives
Price reaction · baseline $1.2 (2023-10-30 close) · hit after-hours · 3 other LXRX headline(s) in the window, move may be shared
day 0 close · peak
+3.3%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+111%
120-day peak, hindsight
Typical move
11%
average across 13 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
Sotagliflozin
Phase 3 · Type 1 Diabetes Mellitus